Wednesday, September 11, 2024

FDA Grants Accelerated Approval for Rezdiffra (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH)

›
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohe...
Tuesday, September 10, 2024

FDA Approves Xolremdi (mavorixafor) for Use in Patients with WHIM Syndrome

›
X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced ...

FDA Approves Exblifep (cefepime/enmetazobactam) for the Treatment of Complicated Urinary Tract Infections,

›
Allecra Therapeutics (“Allecra”), a biopharmaceutical company developing novel therapies to combat antibiotic resistance, announced today th...
Monday, September 9, 2024

FDA Approves Fruzaqla (fruquintinib) for Previously Treated Metastatic Colorectal Cancer

›
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved  Fruzaqla ™ (fruquintinib), an oral...
Friday, September 6, 2024

Salt Substitutes Help Prevent High Blood Pressure

›
Replacing regular salt with a salt substitute can reduce high blood pressure in older adults, a new study has found. Older adults who use a ...
Thursday, September 5, 2024

Salt Substitutes Help Prevent High Blood Pressure

›
A new study has found that replacing regular salt with a salt substitute can reduce high blood pressure in older adults. Older adults who us...
Wednesday, September 4, 2024

FDA Approves Fruzaqla (fruquintinib) for Previously Treated Metastatic Colorectal Cancer

›
Takeda announced the U.S. Food and Drug Administration (FDA) has approval of  Fruzaqla™ (fruquintinib), an oral targeted therapy for adults ...
Tuesday, September 3, 2024

Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer

›
For patients with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma who experienced disease progression on first-line che...
Monday, September 2, 2024

Cefepime-Taniborbactam Superior to Meropenem for Complicated UTI

›
For adults with complicated urinary tract infection (UTI), including acute pyelonephritis, cefepime-taniborbactam is superior to meropenem, ...
Friday, August 30, 2024

Drug That Treats Cocaine Addiction May Curb Colon Cancer

›
A drug first developed to treat cocaine addiction might also help slow the spread of advanced colon cancer, a new study suggests. The drug v...
Thursday, August 29, 2024

Drug Used to Treat Rheumatoid Arthritis May Also Help Prevent It

›
A clinical trial  showed that the  drug abatacept (Orencia) – which is already used to treat diagnosed rheumatoid arthritis – also can preve...
Wednesday, August 28, 2024

FDA Approves Aurlumyn (iloprost) as the First Medication to Treat Severe Frostbite

›
The U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finge...
Tuesday, August 27, 2024

Chugai files for additional indication of Evrysdi for pre-symptomatic SMA and additional dosage for infants up to 2 months of age

›
Chugai Pharmaceutical Co., Ltd. announced that it filed regulatory application with the Ministry of Health, Labour and Welfare (MHLW) of “Ev...
Monday, August 26, 2024

Tapinarof Cream Under FDA Review for Atopic Dermatitis Indication | MDedge Dermatology

›
Dermavant Sciences announced  the company's  submission of  supplemental New Drug Application (sNDA) to the Food and Drug Administration...
Saturday, August 24, 2024

FDA approves tepotinib for metastatic non-small cell lung cancer | FDA

›
FDA approves tepotinib for metastatic non-small cell lung cancer On February 15, 2024, the Food and Drug Administration granted traditional ...